Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice

[1]  C. Schneider.  Lipids in health and disease. , 2010, Molecular nutrition & food research.

[2]  A. M. Cabral,et al.  Endogenous angiotensin II modulates nNOS expression in renovascular hypertension. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  S. Bhardwaj,et al.  Molecular genetics of atherosclerosis , 2009, Human Genetics.

[4]  B. Hendry,et al.  The Regulation of Mesangial Cell Proliferation , 2008, Nephron Experimental Nephrology.

[5]  B. Nogueira,et al.  Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. , 2007, Archives of medical research.

[6]  A. Eddy,et al.  Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. , 2007, American journal of physiology. Renal physiology.

[7]  J. Martin,et al.  The pathology of ageing: concepts and mechanisms , 2007, The Journal of pathology.

[8]  Je Martin,et al.  Renal ageing , 2007, The Journal of pathology.

[9]  Raymond Coleman,et al.  A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. , 2006, Acta histochemica.

[10]  Z. Kmieć,et al.  Central regulation of food intake in ageing. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[11]  U. Berg,et al.  Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  T. Jiang,et al.  Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. , 2005, Kidney international.

[13]  R. M. Arruda,et al.  Evaluation of Vascular Function in Apolipoprotein E Knockout Mice With Angiotensin-Dependent Renovascular Hypertension , 2005, Hypertension.

[14]  L. Lerman,et al.  Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia , 2005, Hypertension.

[15]  S. Bagnasco.  Role and regulation of urea transporters , 2005, Pflügers Archiv.

[16]  C. Baylis.  Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system , 2005, Experimental Gerontology.

[17]  Z. Massy,et al.  Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  P. Nastalek,et al.  Mouse models of experimental atherosclerosis. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[19]  E. Ritz,et al.  No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  L. Wagner,et al.  Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. , 2003, Kidney international.

[21]  AntoninoNicoletti,et al.  Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice , 2003 .

[22]  M. Gervais,et al.  Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Kumar,et al.  Expanding the living related donor pool in renal transplantation: use of marginal donors. , 2003, The Journal of urology.

[24]  D. Heudes,et al.  Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  C. Napoli,et al.  Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease , 2002, Circulation.

[26]  C. Alpers,et al.  Renal Injury in Apolipoprotein E–Deficient Mice , 2002, Laboratory Investigation.

[27]  O. Carretero,et al.  Role of neuronal nitric oxide synthase in the macula densa. , 2001, Kidney international.

[28]  C. Napoli,et al.  Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. , 2001, Journal of the American Society of Nephrology : JASN.

[29]  C. Napoli,et al.  Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. , 2001, Mayo Clinic proceedings.

[30]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[31]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[32]  H. Ha,et al.  Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. , 1999, Kidney international.

[33]  J. Morrow,et al.  Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[34]  D. Fliser,et al.  Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.

[35]  B. Kasiske,et al.  Early glomerular changes in rats with dietary-induced hypercholesterolemia. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  H. Schächinger,et al.  Accelerated decline in renal perfusion with aging in essential hypertension. , 1994, Hypertension.

[37]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[38]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Faragher,et al.  Age-associated changes in the kidney of the laboratory mouse. , 1989, Age and ageing.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  M. Banach,et al.  Statin therapy in the elderly: a review. , 2010, Archives of gerontology and geriatrics.

[42]  B. Gallimore,et al.  Characterization of a mouse model of chronic uremia , 2004, Urological Research.

[43]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.